EIMS, small Higher Education Institution, operating in Malta in Dental education ( www.eims.edu.mt). EIMS' target are medical professionals involved in a continuous cycle of professional practice, reflective professional development, and embedded research to improve their service for the benefit of patients and the community. EIMS would like to take a partnership with MeMoSA® – MOBILE MOUTH SCREENING ANYWHERE (https://memosa.my). could you prepare a report on the oral cancer in Europe, highlighting how MeMoSA® APP could be successfully and usefully integrated in in undergraduate and postgraduate education..
Oral cancer is a significant public health issue in Europe, with rising incidence and mortality rates. Early detection and continuous monitoring are crucial for improving patient outcomes. EIMS, a small Higher Education Institution in Malta specializing in dental education, aims to enhance its curriculum by integrating innovative technologies. This report explores the current state of oral cancer in Europe and proposes the integration of the MeMoSA® APP into EIMS' undergraduate and postgraduate programs to improve early detection, diagnosis, and treatment of oral cancer.
EIMS (European Institute of Medical Sciences) is dedicated to providing high-quality dental education to medical professionals. The institution focuses on continuous professional development, reflective practice, and embedded research to enhance patient care and community health.
MeMoSA® (Mobile Mouth Screening Anywhere) is a mobile application designed to facilitate the early detection and monitoring of oral cancer. The app allows users to capture and share images of oral lesions with healthcare professionals for remote assessment.
Oral cancer is a growing concern in Europe, with approximately 75,000 new cases and 20,000 deaths annually. The incidence rates vary across countries, with higher rates observed in Eastern Europe. Risk factors include tobacco use, alcohol consumption, and human papillomavirus (HPV) infection.
Early detection of oral cancer significantly improves survival rates. However, many cases are diagnosed at advanced stages due to a lack of awareness, limited access to screening, and insufficient training among healthcare professionals.
Integrating the MeMoSA® APP into EIMS' dental education programs offers a valuable opportunity to enhance the early detection and management of oral cancer. By incorporating this innovative technology into both undergraduate and postgraduate curricula, EIMS can equip future dental professionals with the skills and knowledge needed to improve patient outcomes and contribute to the fight against oral cancer in Europe.
By taking these steps, EIMS can position itself as a leader in dental education and contribute to the global effort to combat oral cancer.